Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;12(3):165-170.
doi: 10.1111/cen3.12644. Epub 2021 May 17.

Emerging infectious diseases, vaccines and Guillain-Barré syndrome

Affiliations
Review

Emerging infectious diseases, vaccines and Guillain-Barré syndrome

Haruki Koike et al. Clin Exp Neuroimmunol. 2021 Aug.

Abstract

The recent outbreak of Zika virus infection increased the incidence of Guillain-Barré syndrome (GBS). Following the first reported case of GBS after Zika virus infection in 2013, there has been a considerable increase in the incidence of GBS in endemic countries, such as French Polynesia and Latin American countries. The association between coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and GBS is another emerging research hotspot. Electrophysiological studies have suggested that GBS patients associated with Zika virus infection or COVID-19 tend to manifest acute inflammatory demyelinating polyneuropathy, rather than acute motor axonal neuropathy (AMAN). Causative autoantibodies, such as anti-ganglioside antibodies in AMAN associated with Campylobacter jejuni infection, have not been identified in GBS associated with these emerging infectious diseases. Nevertheless, recent studies suggested molecular mimicry between these viruses and human proteins related to GBS. Recent studies have shown the efficacy of new vaccines, containing artificial messenger RNA encoding the spike protein of SARS-CoV-2, against COVID-19. These vaccines are now available in many countries and massive vaccination campaigns are currently ongoing. Although there are long-standing concerns about the increased risk of GBS after inoculation of conventional vaccines, the risk of GBS is not considered a legitimate reason to limit administration of currently available vaccines, because the benefits outweigh the risks.

Keywords: Guillain–Barré syndrome; acute inflammatory demyelinating polyneuropathy; acute motor axonal neuropathy; antecedent infection; vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Typical pathological findings of acute inflammatory demyelinating polyneuropathy. A cross‐section of a sural nerve biopsy specimen. The cytoplasm of a macrophage invading the basement membrane surrounding a myelinated fiber (arrowheads) contains myelin debris resulting from phagocytosis. The arrow indicates a demyelinated axon. A macrophage located outside of the basement membrane tube of a myelinated fiber is indicated by an asterisk. Uranyl acetate and lead citrate staining. Scale bar, 2 μm.

Similar articles

Cited by

References

    1. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain‐Barré syndrome. Lancet. 2021;397(10280):1214–28. - PubMed
    1. McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain‐Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63. - PubMed
    1. Prineas JW. Acute idiopathic polyneuritis. An electron microscope study. Lab Invest. 1972;26(2):133–47. - PubMed
    1. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, et al Guillain‐Barré syndrome in northern China. the spectrum of neuropathological changes in clinically defined cases. Brain. 1995;118(Pt 3):577–95. - PubMed
    1. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of miller fisher syndrome. Ann Neurol. 1992;31(6):677–9. - PubMed